Exclusive Summary

• Universal Demand & Fast Turnover: As a WHO Essential Medicine, it is the absolute global first-line choice for antipyretic and analgesic needs, guaranteeing massive, continuous consumer demand.
• Overwhelming Cost Advantage: Leveraging China's integrated API-to-finished-dose manufacturing capacity, it offers highly competitive pricing, unlocking exceptional profit margins for global distributors.
• Fast-Track Access & Uninterrupted Supply: Supported by internationally recognized GMP standards and ready-to-use registration dossiers (CTD), securing rapid regulatory approval and resilient bulk product supply.